Kinase inhibitors and method of treating cancer
US8481533B2 · kind B2 · utility
17Cited by
2References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 21, 2012 |
| Grant date | Jul 9, 2013 |
| Priority date | — |
| Expiry date | Jun 21, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D413/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to a compound represented by the following structural formula and pharmaceutically acceptable salts thereof:Compounds represented by this structural formula are kinase inhibitors and are therefore disclosed herein for the treatment of cancer. Definitions for the variables in the structural formula are provided herein.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.